Notice of Closed Meeting, 43238 [2017-19500]
Download as PDF
<![CDATA[
43238
ACTION:
Federal Register / Vol. 82, No. 177 / Thursday, September 14, 2017 / Notices
Notice of meeting.
In accordance with section
10(a)(2) of the Federal Advisory
Committee Act, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
Advisory Committee on Immunization
Practices (ACIP).
This meeting is open to the public,
limited only by the space available.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt is October 11, 2017.
Written comments must include full
name, address, organizational
affiliation, email address of the speaker,
topic being addressed and specific
comments. Written comments must not
exceed one single-spaced typed page
with 1-inch margins containing all items
above. Only those written comments
received 10 business days in advance of
the meeting will be included in the
official record of the meeting. Public
comments made in attendance must be
no longer than 3 minutes and the person
giving comments must attend the public
comment session at the start time listed
on the agenda. Time for public
comments may start before the time
indicated on the agenda. The meeting
will be webcast live via the World Wide
Web; for instructions and more
information on ACIP please visit the
ACIP Web site: https://www.cdc.gov/
vaccines/acip/.
DATES: The meeting will be held on
October 25, 2017, 8:00 a.m. to 6:00 p.m.,
EDT, and October 26, 2017 8:00 a.m. to
3:15 p.m. EDT.
ADDRESSES: 1600 Clifton Road NE.,
Atlanta, GA 30329, CDC, Tom Harkin
Global Communications Center, Kent
‘Oz’ Nelson Auditorium.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, CDC, NCIRD;
email: ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:41 Sep 13, 2017
Jkt 241001
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters to be Considered: The agenda
will include discussions on adult
immunization schedule, child/
adolescent immunization schedule,
influenza vaccines, anthrax vaccine,
Japanese encephalitis vaccines, hepatitis
vaccines, herpes zoster vaccines, human
papillomavirus vaccines, mumps
vaccine, pneumococcal vaccines,
respiratory syncytial virus vaccine and
immunization safety update. A
recommendation vote is scheduled for
adult immunization schedule, child/
adolescent immunization schedule,
hepatitis vaccines and herpes zoster
vaccines. A Vaccines for Children vote
is scheduled for hepatitis vaccines.
Agenda items are subject to change as
priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–19497 Filed 9–13–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting.
The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title
5 U.S.C., and the Determination of the
Director, Management Analysis and
Services Office, CDC, pursuant to Pub.
L. 92–463.
Name of Committee: Safety and
Occupational Health Study Section (SOHSS),
National Institute for Occupational Safety
and Health (NIOSH).
Date: October 31–November 1, 2017.
Time: 8:00 a.m.–5:00 p.m., CST.
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Place: The Wit Hotel, 201 North State
Street, Chicago, Illinois 60601.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the study
section to consider safety and occupational
health-related grant applications.
For Further Information Contact: Price
Connor, Ph.D., NIOSH Health Scientist, CDC
2400 Executive Parkway, Atlanta, Georgia
30345, (404) 498–2511, spc3@cdc.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–19500 Filed 9–13–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting.
The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title
5 U.S.C., and the Determination of the
Director, Management Analysis and
Services Office, CDC, pursuant to Public
Law 92–463.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—PAR 13–129, NIOSH
Member Conflict Special Emphasis Panel.
Date: October 25, 2017.
Time: 1:00 p.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: The meeting will include the
initial review, discussion, and evaluation of
applications received in response to PAR 13–
129, NIOSH Member Conflict Special
Emphasis Panel.
For FuRther Information Contact: Nina
Turner, Ph.D. Scientific Review Officer, CDC,
1095 Willowdale Road, Morgantown, West
Virginia 26506, (304) 285–5976, nxt2@
cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\14SEN1.SGM
14SEN1
]]>Agencies
[Federal Register Volume 82, Number 177 (Thursday, September 14, 2017)]
[Notices]
[Page 43238]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19500]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting.
The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Pub. L. 92-463.
Name of Committee: Safety and Occupational Health Study Section
(SOHSS), National Institute for Occupational Safety and Health
(NIOSH).
Date: October 31-November 1, 2017.
Time: 8:00 a.m.-5:00 p.m., CST.
Place: The Wit Hotel, 201 North State Street, Chicago, Illinois
60601.
Agenda: The meeting will convene to address matters related to
the conduct of Study Section business and for the study section to
consider safety and occupational health-related grant applications.
For Further Information Contact: Price Connor, Ph.D., NIOSH
Health Scientist, CDC 2400 Executive Parkway, Atlanta, Georgia
30345, (404) 498-2511, spc3@cdc.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-19500 Filed 9-13-17; 8:45 am]
BILLING CODE 4163-18-P
